Gene Query: RNF166

Dataset Description Geneva Score
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 35.79
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 24.83
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 24.5
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 20.67
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 19.6
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 19.38
Intrahepatic MAIT cell gene expression revealed by RNA-seq 18.5
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 18.23
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 17.73
Human neutrophil genome during PMA- and E. coli encounter-induced activation 17.73
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 17.21
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 16.1
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 15.8
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 15.34
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 14.71
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 13.95
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 13.85
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 13.38
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 13.01
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 13.01
CircRNAome diversity in human mature B-cells, T-cells and monocytes 12.72
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 12.68
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 12.68
Transcriptome of activated human and mouse MAIT cells 12.61
Stem and effector CD8 T-cells from human cancers 12.34
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 11.94
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 11.79
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 11.13
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 11.01
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 10.88
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 10.77
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 10.77
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 10.67
Expression and functions of long noncoding RNAs during human T helper cell differentiation 10.47
Identification of global regulators of T-helper cell lineage specification 10.22
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 10.22
Gene expression signatures of innate lymphoid cells from human blood 10.2
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 10.14
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 10.08
mRNA expression profile of Lymphocytes by high-throuput sequencing 9.99
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 9.96
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 9.95
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 9.85
Transcriptional profiles of normal human mature B cells 9.83
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 9.44
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 9.33
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 9.33
Single cell transcriptome of peritoneal cells 9.22
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 9.11
Transcriptome-wide identification of CELF2 functional targets in T cells 9.1
Transcriptome of Stabilin-1 siRNA transfected human monocytes 8.99
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 8.45
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 8.37
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 8.28
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 8.11
Pharmacologic inhibition of STAT5 in AML 8.11
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 8.08
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 7.88
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 7.82
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 7.78
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 7.62
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 7.56
Transcriptomes of human monocytes after ex vivo exposure to uric acid 7.51
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 7.47
AUF-1 affected genes in human skin cells 7.43
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 7.32
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 7.32
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 7.31
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 7.23
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 7.2
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.11
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 7.09
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 6.99
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 6.84
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 6.84
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 6.8
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 6.55
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 6.5
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 6.46
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 6.42
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 6.41
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 6.31
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 6.3
A single cell reference map for human blood and tissue T cell activation 6.3
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.02
Silencing p300 in MCF7 cells to study expression and alternative splicing 5.95
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 5.85
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.8
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 5.79
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 5.79
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 5.79
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 5.79
Microglia innatly develop within cerebral organoids 5.72
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 5.64
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 5.61
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 5.55
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 5.55
Targeting MTHFD2 in Acute Myeloid Leukemia 5.51
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 5.51
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 5.38
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 5.37
Regulating Interleukin-2 activity with engineered receptor signaling clamps 5.33
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 5.32
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 5.24
Primary Human B-cell Temporal Response to CD40L Stimulation 5.23
Transcriptome analysis of CNS leukemia 5.21
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 5.21
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 5.19
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 5.14
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 5.14
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 5.13
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 5.12
RNA-seq analysis of AML cells in response to ASLAN003 5.09
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 5.07
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 5.0
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 4.84
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 4.82
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 4.81
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 4.77
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 4.76
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.73
Capturing the Interactome of Newly Transcribed RNA 4.72
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.72
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.67
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 4.65
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 4.64
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 4.59
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 4.54
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 4.52
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 4.52
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 4.49
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 4.46
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 4.46
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 4.43
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 4.35
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 4.32
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 4.2
CROP-Seq in Primary Human T Cells 4.19
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 4.16
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 4.16
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 4.11
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 4.04
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 4.04
Integrating single-cell transcriptomic data across different conditions, technologies, and species 4.03
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 3.98
Transcriptome wide analysis of classically and alternatively activated macrophages 3.94
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 3.93
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 3.92
ZIKV infection of monocytes activates inflammasome pathways 3.81
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 3.79
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.75
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.75
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 3.74
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 3.74
Identification of renal resident macrophages across species 3.74
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 3.7
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 3.7
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 3.65
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 3.61
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 3.6
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.59
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.59
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.55
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 3.55
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.54
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 3.52
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 3.52
Co-transcriptional loading of RNA export factors shapes the human transcriptome 3.47
RNAseq of HEK293 cells after Chtop knockdown 3.47
Impact of dieldrin on transcription in Jurkat T cells 3.47
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.42
RNA-seq of resting and activated CD4+ T cells +-JQ1 3.41
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 3.41
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 3.39
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 3.38
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 3.38
BACH2 in human plasma cell fate decision 3.37
Transcriptome analysis of peripheral blood monocytes 3.32
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 3.3
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 3.3
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 3.3
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 3.26
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 3.21
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 3.18
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 3.18
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 3.15
The evolution of N6-methyladenosine in primates 3.09
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 3.05
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 3.0
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 3.0
Transcriptomes of oxLDL exposed trained monocytes 2.97
oxLDL exposed trained monocytes 2.97
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 2.94
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 2.94
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 2.92
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 2.92
PTHrP overexpression in MCF7 cells 2.91
Human cells contain natural double-stranded RNAs with potential regulatory capacity 2.9
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 2.89
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 2.88
Spliceosomal disruption of the non-canonical BAF complex in cancer 2.88
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.85
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 2.85
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 2.85
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 2.83
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 2.8
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 2.77
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 2.76
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 2.76
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 2.76
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 2.75
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 2.75
Short and Long RNA sequencing of human mature erythrocytes 2.72
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 2.71
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.71
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.71
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 2.69
Transcriptomic analysis of LSD1 2.68
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 2.66
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 2.65
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 2.62
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 2.62
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 2.6
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 2.59
Regulation of protein translation during mitosis 2.57
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.56
EWSR1 influences alternative splicing through direct and indirect mechanisms 2.54
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 2.53
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 2.53
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 2.51
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 2.51
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 2.5
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 2.48
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 2.47
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.46
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 2.45
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.44
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 2.44
Characterization of human ILC2 subsets 2.4
ENCODE Cold Spring Harbor Labs Long RNA-seq 2.36
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 2.36
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.36
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 2.35
Gene expression in GBM with Cav3.2 inhibition 2.34
RNA-Seq and expression data from human adipose tissue 2.34
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.34
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.33
CD86 regulates a pro-survival signal in myeloma cells 2.31
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 2.3
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 2.29
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 2.27
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 2.25
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 2.24
DART-seq: an antibody-free method for global m6A detection 2.24
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.24
Transcriptomes in healthy and CHB fetal hearts 2.22
Leucegene: AML sequencing (part 6) 2.19
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 2.17
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.16
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 2.12
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 2.11
U2AF1 mutations alter splice site recognition in hematological malignancies 2.09
mRNA expression profile of Lymphocytes 2.09
ETV7 and interferon response 2.07
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 2.07
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 2.07
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 2.05
Transcriptional profile in human S. haematobium infection 2.05
naive T cell heterogeneity after neonatal thymectomy 2.04
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 2.04
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.03
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 2.03
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 2.03
Transcriptome Profiling of Human Primary Monocytes 2.0
Effects of rFVIIIFc on human macrophages 1.98
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.95
Gene expression profiling of leukemia cells following asparagine depletion 1.95
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.92
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.92
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 1.9
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 1.89
RNA sequencing of T-ALL (COG study) 1.86
Analyses of T-ALL (COG study) 1.86
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 1.85
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 1.85
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 1.85
Transcriptional profiling of microglia; current state of the art and future perspectives 1.84
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.83
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 1.81
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.8
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.79
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 1.79
Transcription control by the ENL YEATS domain in acute leukemia 1.75
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 1.75
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.74
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.68
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.68
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 1.68
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 1.67
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.67
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 1.67
Aging-associated patterns in the expression of human endogenous retroviruses 1.67
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.65
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.65
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.63
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 1.6
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 1.58
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.58
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.58
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.55
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 1.54
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 1.54
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 1.54
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.54
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.53
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 1.53
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 1.53
Bone marrow derived human B cells [normal proB] 1.52
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.51
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.5
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.5
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.5
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.49
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 1.49
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 1.44
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.43
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.42
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.42
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.42
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.42
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 1.42
Tpl-2 and MEK small molecule inhibitors 1.41
Tpl-2 small molecule project 1.41
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.38
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.37
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 1.36
Irf9 function in immunity in mouse 1.36
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.36
Reprogrammed myeloid cell transcriptomes in NSCLC 1.34
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.34
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.34
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.33
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.33
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 1.31
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 1.3
Single-Cell Genotyping of Transcriptomes 1.29
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.29
circRNA profile in hypopharyngeal cancer 1.27
RNA-Seq in neutrophils from Antiphospholipid Syndrome 1.25
A practical evaluation of alignment algorithms for RNA variant calling analysis 1.24
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 1.24
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 1.24
Genome-wide discovery of human splicing branchpoints [RNAse] 1.24
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 1.23
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 1.23
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 1.22
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.22
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.2
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.19
Proliferation-correlated expression 1.17
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 1.16
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.16
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.14
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.14
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.14
Functional significance of the HIV-1 Tat signature amino acid residues 1.14
Identification of long noncoding RNAs in T-ALL cell lines 1.14
Hepatosplenic T cell lymphoma 1.09
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 1.09
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 1.08
Transcriptome analysis of SKI knock-out in HL60 cells 1.08
Discovering human diabetes-risk gene function with genetics and physiological assays 1.06
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.05
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 1.04
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.04
RNA-seq analysis upon ARID1B overexpression 1.01
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.0
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 1.0
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 1.0
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.99
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.99
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.98
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.97
Clinker: visualizing fusion genes detected in RNA-seq data 0.95
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.94
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.94
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.94
TT-Seq captures the human transient transcriptome 0.93
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 0.92
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.91
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 0.91
Macrophage Ad5f35 PhenoMap 0.91
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.91
Targeted enhancer activation by a subunit of the integrator complex 0.87
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.86
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.86
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.84
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.84
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.78
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.75
Transcriptomic analysis of human macrophages in 3D 0.74
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.74
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.74
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.71
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.7
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.66
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.66
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 0.66
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.65
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 0.61
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.59
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 0.59
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.58
A map of gene expression in neutrophil-like cell lines 0.58
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 0.58
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 0.58
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 0.57
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.57
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 0.54
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.53
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.53
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.53
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 0.52
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.52
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 0.49
NR2F2 study 0.48
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 0.48
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.48
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.48
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.47
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.47
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.45
Leucegene: ALL sequencing 0.44
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 0.44
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.43
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.43
Trascriptome of thyroid cancer-induced macrophages 0.43
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.41
SRSF1 role in cellular gene expression and splicing 0.4
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.4
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 0.39
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 0.39
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.38
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.37
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.35
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.35
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.35
Genome-wide discovery of human splicing branchpoints 0.34
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.31
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.31
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.31
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.3
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.27
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.26
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.25
MAIT cell RNA sequencing 0.25
Oncogenic roles of ARID5B in T-ALL 0.25
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.25
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.24
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.22
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.22
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 0.22
Energy Metabolism during Anchorage-Independence 0.22
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.21
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.21
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.2
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.2
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 0.19
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.17
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.17
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 0.15
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.15
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.15
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.14
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.14
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 0.12
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.11
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 0.11
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 0.1
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.1
MHC Transcriptomic landscape at haplotype-specific resolution 0.1
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.1
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.1
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.07
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.07
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.07
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.07
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 0.06
Specific molecular signatures underlie response to decitabine in CMML 0.06
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.06
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.05
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.05
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.04
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.03
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.03
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.03
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.02
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.01
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.01
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation